Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific(U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup(France)
(PRWEB) November 10, 2014
The “Clinical Chemistry Analyzer Market by Test Type (Electrolyte, Liver, Basic Metabolic, Thyroid Function, Lipid, Renal, Specialty Chemicals), Product (Systems & Reagents), & by End User (Academic Research, Laboratories, Hospitals) - Global Forecast to 2019" report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, challenges and strategies impacting the global market along with the estimates and forecasts of the revenue and market share analysis.
78 market data tables
200 pages and in-depth TOC on "Clinical Chemistry Analyzer Market"
The global Clinical Chemistry Analyzers market was estimated at $8,965 million in 2014. This market is expected to grow at a CAGR of 5.52% between 2014 and 2019, to reach $11,728.01 million in 2019.
For more Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=144027310
Clinical chemistry analyzers are the most widely used equipments in clinical laboratories. A large quantity of reagents and other consumables are required for various types of tests. Basic metabolic panel tests are the largest test segment for the clinical chemistry analyzer market in 2014, whereas the lipid profile test segment is expected to grow at the highest CAGR between 2014 and 2019. Growth in the basic metabolic panel tests, aided by growing trends of preventive medicine and increasing incidence in lifestyle disease will drive the growth of the market.
The global clinical chemistry analyzers market report segments this market on the basis of products, test, end users and regions. The clinical chemistry analyzers segment is further divided into four subsegments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), and Very large (2,000 Tests/H). The reagent segment is categorized in to calibrators, controls, standards and other reagents. The test segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests.
Get PDf Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=144027310
The geographic segments included in this report are the Americas, Europe, BRIC, Japan and Rest of the World (RoW). The geographic analysis reveals that Americas accounted for the largest share in the global market in 2014. The BRIC regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing demand for automation from this region.
The key drivers for this market are rise in number of lifestyle diseases; automation of laboratories will aid the growth of this market. Increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation will drive the demand for clinical chemistry analyzers products. Growth in the clinical chemistry market will drive the growth of the clinical chemistry analyzers market.
The major players in the clinical chemistry analyzer market include Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific (U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup (France), Mindray (China), Horiba (Japan).
Browse Related Reports:
Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019
Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 full time analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical info-graphics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets